The UK Government yesterday answered a written Parliamentary Question (a mechanism for formal statements of policy) on advance purchases of a malaria vaccine.
CGD Policy Blogs
A group of researchers has published proposals for a new mechanism to improve collaboration and knowledge sharing on the development of medicines for tropical diseases.
In June 2004, at Sea Island, the G8 endorsed the Global HIV Vaccine Enterprise. This is a mechanism, first proposed in June 2003, which aims to enhance coordination, information sharing and global collaboration amongst the world's HIV vaccine researchers in industrialized and developing countries in both private and public sectors.
Sebastian Mallaby writes in today's Washington Post (requires free registration) of the Bush administration's opportunity to find common ground with European allies on the issue of AIDS vaccine development.
The essence of an advance market commitment is that sponsors would guarantee that, if a suitable vaccine is developed, they will pay for it to be bought and used in developing countries.
The Aeras Global TB Vaccine Foundation and the David Geffen School of Medicine at UCLA today announced they have begun the first clinical trial of a live recombinant tuberculosis vaccine in the U.S.